Top Purchase Related
Home
>
Node
>
Subnode

Nonalcoholic fatty liver

Spahr, L.

Revue Medicale Suisse 7(279): 227

2011

ISSN/ISBN: 1660-9379
PMID: 21387725
Document Number: 649362

Document emailed within 1 workday
Secure & encrypted payments

Jin, H-Bin.; Gu, Z-Ying.; Yu, C-Hui.; Li, Y-Ming. 2005: Association of nonalcoholic fatty liver disease with type 2 diabetes: clinical features and independent risk factors in diabetic fatty liver patients Hepatobiliary and Pancreatic Diseases International: Hbpd Int 4(3): 389-392
Chen, J.; Zheng, R.-D.; Xu, C.-R.; Wu, W.-P. 2009: Expression and significance of liver X receptor-alpha in nonalcoholic fatty liver disease in rats Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 23(4): 265-268
Chen, L.-l.; Deng, X.-q.; Li, N.-x. 2007: Effects of calorie restriction on SIRT1 expression in liver of nonalcoholic fatty liver disease: experiment with rats Zhonghua Yi Xue Za Zhi 87(20): 1434-1437
Pérez Blanco, L.A.; Vilar Gómez, E.; Martínez Pérez, Y.; Calzadilla Bertot, L. 2013: Nonalcoholic fatty liver disease. a current perspective Acta Gastroenterologica Latinoamericana 43(3): 254-260
Grigor'eva, I.N. 2011: UDCA in the treatment of nonalcoholic fatty liver disease Eksperimental'naia i Klinicheskaia Gastroenterologiia 11: 79-85
Grigor'eva, I.N. 2011: UDCA in the treatment of nonalcoholic fatty liver disease Eksperimental'naia i Klinicheskaia Gastroenterologiia 9: 125-131
Podymova, S.D. 2016: [The Modern View on Pathogenesis and Treatment of Nonalcoholic Fatty Liver Disease Eksperimental'naia i Klinicheskaia Gastroenterologiia 5: 74-82
Massarrat, S.; Jordan, G.; Sahrhage, G.; Korb, G.; Bode, J.C.; Dölle, W. 1974: Five-year follow-up study of patients with nonalcoholic and nondiabetic fatty liver Acta Hepato-Gastroenterologica 21(3): 176-186
Drapkina, O.M.; Deeva, T.A.; Volkova, N.P.; Ivashkin, V.T. 2014: [Current approaches to diagnosing and treating nonalcoholic fatty liver disease Terapevticheskii Arkhiv 86(10): 116-123
Prompila, N.; Wittayalertpanya, S.; Komolmit, P. 2008: Hepatic cytochrome P450 2E1 activity in nonalcoholic fatty liver disease Journal of the Medical Association of Thailand 91(5): 733-738
Lin, S.C.; Shih, S.C.; Kao, C.R.; Chou, S.Y. 1995: Prevalence of antibodies to hepatitis C virus in patients with nonalcoholic fatty liver Zhonghua Yi Xue Za Zhi 56(2): 80-85
Romanowska, A.; Lebensztejn, D.M. 2010: Evaluation of serum visfatin concentrations in children with nonalcoholic fatty liver disease Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 28(168): 459-461
Casoinic, F.; Sâmpelean, D.; Bădău, C.ăt.ăl.; Prună, L. 2009: Nonalcoholic fatty liver disease--a risk factor for microalbuminuria in type 2 diabetic patients Romanian Journal of Internal Medicine 47(1): 55-59
Kuchmin, A.N.; Rezvan, V.V.; Evsiukov, K.B.; Fomin, A.A.; Karshieva, A.V.; Butikov, V.P. 2010: Condition of the intestinal tract microbiocenosis in patients with nonalcoholic fatty liver disease and the methods of its correction Voenno-Meditsinskii Zhurnal 331(6): 20-26
Fukuhara, T.; Hyogo, H.; Ochi, H.; Fujino, H.; Kan, H.; Naeshiro, N.; Honda, Y.; Miyaki, D.; Kawaoka, T.; Tsuge, M.; Hiramatsu, A.; Imamura, M.; Kawakami, Y.; Aikata, H.; Chayama, K. 2014: Efficacy and safety of sitagliptin for the treatment of nonalcoholic fatty liver disease with type 2 diabetes mellitus Hepato-Gastroenterology 61(130): 323-328
Kolesnikova, O. 2012: Relationship gene polymorphism adipor1 with cardiovascular risk in patients with nonalcoholic fatty liver disease Georgian Medical News 213: 40-44
Giday, S.A.; Ashiny, Z.; Naab, T.; Smoot, D.; Banks, A. 2006: Frequency of nonalcoholic fatty liver disease and degree of hepatic steatosis in African-American patients Journal of the National Medical Association 98(10): 1613-1615
Gupta, N.; Jindal, G.; Nadda, A.; Bansal, S.; Gahukar, S.; Kumar, A. 2020: Prevalence and risk factors for nonalcoholic fatty liver disease in obese children in rural Punjab, India Journal of Family and Community Medicine 27(2): 103-108
Wu, P.; Shu, Y.; Li, M.; Luo, H.; Zhang, G.; Tan, S. 2015: Study on the interaction between matrix metalloproteinases gene polymorphism and central obesity in nonalcoholic fatty liver disease Zhonghua Liu Xing Bing Xue Za Zhi 36(12): 1415-1418
Chernyak, O.O.; Sentsova, T.B.; Vorozhko, I.V.; Tutelyan, V.A.; Gapparova, K.M.; Isakov, V.A. 2015: Genomic, proteomic and metabolomic predictors of nonalcoholic fatty liver disease development in obese patients. Part i Voprosy Pitaniia 84(4): 18-24